About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | AI Echocardiographic Screening of Cardiac Amyloidosis

AI Echocardiographic Screening of Cardiac Amyloidosis

NCT06664866·4 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Cedars-Sinai Medical Center

With

Palo Alto Veteran Affairs Hospital
Providence Heart & Vascular Institute
Northwestern Medicine

Age

22–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients receiving an echocardiogram that is determined to be suspicious by EchoNet-LVH

You may not be if

Patients that decline consent
Patients receiving an echocardiogram that is determined to be not suspicious by EchoNet-LVH

The record

StatusEnrolling by invitation

PhaseNo phase

Taking part500

StartedOct 2024

UpdatedJul 22, 2026

Conditions

Cardiac Amyloidosis

Where4

Cedars Sinai Medical Center
Los Angeles, California, United States
Palo Alto Veteran Affairs Hospital
Palo Alto, California, United States
Northwestern Medicine
Chicago, Illinois, United States